European Journal of Cancer
Volume 45, Issue 2 , Pages 261-267 , January 2009

Evaluation of lymph nodes with RECIST 1.1

  • L.H. Schwartz

      Affiliations

    • Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue (C-276D), NY, USA
    • Corresponding Author InformationCorresponding author: Tel.: +1 (212) 639 5511; fax: +1 (212) 794 4010.
    • ,
  • J. Bogaerts

      Affiliations

    • European Organization for Research and Treatment of Cancer, Data Centre, Brussels, Belgium
    • ,
  • R. Ford

      Affiliations

    • RadPharm, Princeton, NJ, USA
    • ,
  • L. Shankar

      Affiliations

    • Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA
    • ,
  • P. Therasse

      Affiliations

    • GlaxoSmithKline Biologicals, Rixensart, Belgium
    • ,
  • S. Gwyther

      Affiliations

    • East Surrey Hospital, Redhill, Surrey, UK
    • ,
  • E.A. Eisenhauer

      Affiliations

    • National Cancer Institute of Canada – Clinical Trials Group, Kingston, ON, Canada

Received 17 October 2008 ,Accepted 29 October 2008.

References 

  1. Einstein DM, Singer AA, Chilcote WA, Desai RK. Abdominal lymphadenopathy: spectrum of CT findings. Radiographics. 1991;11:457–472
  2. Castellino RA, Marglin SI. Imaging of abdominal and pelvic lymph nodes: lymphography or computed tomography?. Invest Radiol. 1982;17:433–443
  3. Steinkamp H, Cornhel M, Hosten N, et al. Cervical lymphopathy: ration of long to short-axis diameter as a predictor for malignancy. Br J Radiol. 1995;68:266–270
  4. Steinkamp HJ, Hosten N, Richter C, Schedel H, Felix R. Enlarged cervical lymph nodes at helical CT. Radiology. 1994;191:795–798
  5. Glazer GM, Gross BH, Quint LE, Francis IR, Bookstein FL, Orringer MB. Normal mediastinal lymph nodes: number and size according to American Thoracic Society mapping. AJR Am J Roentgenol. 1985;144:261–265
  6. Matsuoka H, Masaki T, Sugiyama M, Atomi Y, Ohkura Y, Sakamoto A. Morphological characteristics of lateral pelvic lymph nodes in rectal carcinoma. Langenbecks Arch Surg. 2007;392:543–547
  7. Bogaerts J, Ford R, Sargent D, et al. Individual patient data analysis to assess modifications to the RECIST criteria. Eur J Cancer. 2009;45:248–260
  8. Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumors: Revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45:228–247
  9. Adachi Y, Sakino I, Matsumata T, Iso Y, Yoh R, Kitano S. Clinical results and prognostic factors of radiologically node-positive gastric carcinoma. J Clin Gastroenterol. 1999;28:140–143
  10. Bonomo L, Ciccotosto C, Guidotti A, Storto ML. Lung cancer staging: the role of computed tomography and magnetic resonance imaging. Eur J Radiol. 1996;23:35–45
  11. Strauss GM, Herndon JE, Sherman DD, et al. Neoadjuvant chemotherapy and radiotherapy followed by surgery in stage IIIA non-small-cell carcinoma of the lung: report of a Cancer and Leukemia Group B phase II study. J Clin Oncol. 1992;10:1237–1244
  12. Schnyder PA, Gamsu G. CT of the pretracheal retrocaval space. AJR. 1981;136:303–308
  13. Dorfman RE, Alpern MB, Gross BH, Sandler MA. Upper abdominal lymph nodes: criteria for normal size determined with CT. Radiology. 1991;180:319–322
  14. Remy-Jardin M, Duyck R, Remy J, et al. Hilar lymph nodes: identification with spiral CT and histologic correlation. Radiology. 1995;196:387–394
  15. Kamiyoshihara M, Kawashima O, Ishikawa S, Morishita Y. Mediastinal lymph node evaluation by computed tomographic scan in lung cancer. J Cardiovasc Surg (Torino). 2001;42:119–124
  16. Kim SH, Kim SC, Choi BI, Han MC. Uterine cervical carcinoma: evaluation of pelvic lymph node metastasis with MR imaging. Radiology. 1994;190:807–811
  17. Arii K, Takifuji K, Yokoyama S, et al. Preoperative evaluation of pelvic lateral lymph node of patients with lower rectal cancer: comparison study of MR imaging and CT in 53 patients. Langenbecks Arch Surg. 2006;391:449–454
  18. van den Brekel MWM, Castelijns JA, Snow GB. Detection of lymph node metastases in the neck: radiologic criteria. Radiology. 1994;192:617–618
  19. McLoud TC, Bourgouin PM, Greenberg RW, et al. Bronchogenic carcinoma: analysis of staging in the mediastinum with CT by correlative lymph node mapping and sampling. Radiology. 1992;182:319–323
  20. Dales RE, Stark RM, Raman S. Computed tomography to stage lung cancer. Approaching a controversy using meta-analysis. Am Rev Respir Dis. 1990;141:1096–1101
  21. Fukuya T, Honda H, Hayashi T, et al. Lymph-node metastases: efficacy for detection with helical CT in patients with gastric cancer. Radiology. 1995;197:705–711
  22. Yang WT, Lam WW, Yu MY, Cheung TH, Metreweli C. Comparison of dynamic helical CT and dynamic MR imaging in the evaluation of pelvic lymph nodes in cervical carcinoma. AJR Am J Roentgenol. 2000;175:759–766
  23. Scher HI, Halabi S, Tannock I, et al. Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testerone: recommendations of the Prostate Cancer Clinical Trials Working Group. J Clin Oncol. 2008;26:1148–1159
  24. Schwartz LH, Colville JA, Ginsberg MS, et al. Measuring tumor response and shape change on CT: esophageal cancer as a paradigm. Ann Oncol. 2006;17:1018–1023
  25. Lewis E, Bernardino ME, Salvador PG, Cabanillas FF, Barnes PA, Thomas JL. Post-therapy CT-detected mass in lymphoma patients: is it viable tissue?. J Comput Assist Tomogr. 1982;6:792–795
  26. Cheson BD, et al. NCI Sponsored International Working Group Report of an international workshop to standardize response criteria for non-Hodgkin’s lymphomas. J Clin Oncol. 1999;17:1244
  27. Cheson BD, Pfistner B, Juewid M, et al. Revised response criteria for malignant lymphoma. J Clin Oncol. 2007;25:579–586
  28. Anzai Y. Superparamagnetic iron oxide nanoparticles: nodal metastases and beyond. Top Magn Reson Imaging. 2004;15:103–111
  29. Mack MG, Balzer JO, Straub R, Eichler K, Vogl TJ. Superparamagnetic iron oxide-enhanced MR imaging of head and neck lymph nodes. Radiology. 2002;222:239–244
  30. Kernstein K, Stanford W, Mullan BF, et al. PET, SV, and MRI with combidex for mediastinal staging in non-small cell lung carcinoma. Ann Thorac Surg. 1999;68:1022–1028

PII: S0959-8049(08)00875-7

doi: 10.1016/j.ejca.2008.10.028

European Journal of Cancer
Volume 45, Issue 2 , Pages 261-267 , January 2009

Article Tools

* Image Usage & Resolution